Kaso ng COVID-19 sa Central Visayas mahigit 18,000 na

By Dona Dominguez-Cargullo August 20, 2020 - 07:40 AM

Sumampa na sa mahigit 18,000 na ang kaso ng COVID-19 sa Central Visayas.

Ito ay makaraang makapagtala pa ng dagdag na 69 na bagong kaso ng sakit kahapon.

Ayon sa DOH-Central Visayas Center for Health Development, 18,055 na ang total confirmed cases ng COVID-19 sa rehiyon.

Sa nasabing bilang, 3,052 na lang ang aktibong kaso.

Umabot naman na sa 1,053 ang bilang ng nasawi dahil sa COVID-19 sa Central Visayas.

Habang nakapagtala ng dagdag na bilang ng recoveries na umabot sa 495 dahilan para umabot na sa 13,950 ang bilang ng mga gumaling sa sakit.

Malaking bilang ng kaso ng COVID-19 sa Central Visayas ay sa Cebu City na nakapagtala na ng 9,419 cases.

Narito naman ang kaso ng COVID-19 sa iba pang mga lalawigan at lungsod sa rehiyon:

Cebu Province – 2,362
– Talisay City – 828
– Minglanilla – 469
– Consolacion – 455
Mandaue City – 2,156
Lapu-Lapu City – 2,112
Negros Oriental – 120
Bohol – 131
Siquijor – 3

 

 

 

TAGS: Central Visayas COVID cases, covid pandemic, COVID-19, covid19, department of health, doh, general community quarantine, Health, Inquirer News, Modified enhanced community quarantine, Modified general community quarantine, News in the Philippines, Radyo Inquirer, State of Emergency, Tagalog breaking news, tagalog news website, Central Visayas COVID cases, covid pandemic, COVID-19, covid19, department of health, doh, general community quarantine, Health, Inquirer News, Modified enhanced community quarantine, Modified general community quarantine, News in the Philippines, Radyo Inquirer, State of Emergency, Tagalog breaking news, tagalog news website

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.